Aquestive Therapeutics, Inc. (AQST) SEC Filings — 2024
30 SEC filings for Aquestive Therapeutics, Inc. (AQST) in 2024.
Filings
- Aquestive Therapeutics Files 8-K — 8-K · Dec 19, 2024
- Aquestive Therapeutics Files 8-K — 8-K · Dec 2, 2024
- Aquestive Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Aquestive Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 8, 2024
- Aquestive Therapeutics Announces Board and Executive Changes — 8-K · Nov 7, 2024
- Aquestive Therapeutics Files 8-K — 8-K · Nov 6, 2024
- Aquestive Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 4, 2024
- Aquestive Therapeutics Files 8-K — 8-K · Oct 25, 2024
- Aquestive Therapeutics Files 8-K — 8-K · Oct 24, 2024
- Aquestive Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 22, 2024
- Aquestive Therapeutics Files 8-K for Bylaws and Exhibits — 8-K · Oct 16, 2024
- Aquestive Therapeutics Files 8-K with Financials — 8-K · Sep 27, 2024
- Aquestive Therapeutics Files 8-K — 8-K · Sep 9, 2024
- Aquestive Therapeutics Files 8-K — 8-K · Aug 14, 2024
- Aquestive Therapeutics Files 8-K — 8-K · Aug 6, 2024
- Aquestive Therapeutics Sells Subsidiary for $30M — 8-K · Jul 25, 2024
- Aquestive Therapeutics Reports Shareholder Vote Matters — 8-K · Jun 21, 2024
- FDA Approves Aquestive's Libervant for Seizures — 8-K · Jun 7, 2024
- Aquestive Therapeutics Names New Directors, Adjusts Exec Pay — 8-K · Jun 6, 2024
- Aquestive Therapeutics Sells MonoSol Rx for $10M — 8-K · May 8, 2024
- Aquestive Therapeutics Files 8-K for Financials — 8-K · May 7, 2024
- Aquestive Therapeutics Files 8-K — 8-K · Apr 29, 2024
- Aquestive Therapeutics Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 26, 2024
- Aquestive Therapeutics Sells Subsidiary MonoSol Rx — 8-K · Apr 22, 2024
- Aquestive Therapeutics, Inc. SC 13G Filing — SC 13G · Apr 1, 2024
- Aquestive Therapeutics Reports Leadership Changes — 8-K · Apr 1, 2024
- Aquestive Therapeutics Enters Material Definitive Agreement — 8-K · Mar 21, 2024
- Aquestive Therapeutics Closes $100M Public Offering — 8-K · Mar 15, 2024
- Aquestive Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Mar 5, 2024
- Aquestive Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 14, 2024